Alkem Labs launches Alfluenza for coronavirus treatment
Alkem Laboratories has launched Favipiravir for the treatment of COVID-19 patients under the brand name ‘Alfluenza’. Favipiravir is approved by the Drug Controller General of India (DCGI) for restricted emergency…